YD Bio Limited (NASDAQ:YDES – Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 25,094 shares, a growth of 124.7% from the June 30th total of 11,169 shares. Based on an average trading volume of 621,113 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.
YD Bio Price Performance
Shares of YDES stock opened at $2.29 on Tuesday. The firm has a fifty day moving average of $2.84 and a two-hundred day moving average of $6.32. YD Bio has a 1-year low of $1.70 and a 1-year high of $25.00.
Hedge Funds Weigh In On YD Bio
A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC boosted its position in YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the quarter. Geode Capital Management LLC owned approximately 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.
About YD Bio
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
See Also
- Five stocks we like better than YD Bio
- Wintrust: A Quiet Regional Bank Posting Loud Results
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
